Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis

Details for Australian Patent Application No. 2001253113 (hide)

Owner Pharmacia and Upjohn Company LLC

Inventors Jensen, Richard K.; Mesfin, GebreMariam

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001253113

PCT Pub. Number WO01/80841

Priority 60198688 20.04.00 US

Filing date 17 March 2001

Wipo publication date 7 November 2001

Acceptance publication date 3 February 2005

International Classifications

A61K 031/00

Event Publications

3 February 2005 Application Accepted

  Published as AU-B-2001253113

2 June 2005 Standard Patent Sealed

9 November 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001253114-Compounds for treating fibromyalgia and chronic fatigue syndrome

2001253112